Boots to become first UK high street pharmacy to offer medical cannabis
Boots first UK high street pharmacy to offer medical cannabis

Boots is set to become the first UK high street pharmacy to offer medical cannabis prescriptions. The new private service, called SureLeaf, will be available through Boots Online Doctor to people in the UK aged 25 and over with eligible chronic pain conditions, generalised anxiety disorder or insomnia.

To be eligible, patients must have previously tried conventional treatments without achieving adequate symptom relief, Boots said. Those interested in the private service will be invited to complete an online assessment, with their suitability reviewed by a clinical team. Those who qualify will then have a video consultation with a specialist consultant. Any proposed prescription will be independently reviewed by a multidisciplinary clinical team, which includes a second independent consultant, Boots said.

Boots partners with University of Nottingham on research

Alongside the launch, Boots said it is partnering with the University of Nottingham in a research programme aimed at building "on the existing real-world evidence and understanding of medical cannabis in chronic pain management". The research will examine patient outcomes for chronic pain, prescribing practices and patient experiences.

Jamie Kerruish, chief healthcare officer at Boots, said: "Millions of people live with ongoing pain and for some, conventional treatments do not provide adequate symptom relief. This can have a significant impact on everyday life, from working and sleeping well to spending time with family and doing the things they enjoy."

Clinical safeguards at every stage

Kerruish added: "Medical cannabis is a specialist area of healthcare and, through SureLeaf, we’re giving eligible patients another treatment option to consider, supported by clinical expertise and robust ongoing care. Ultimately, it’s about helping people explore appropriate options that could help them better manage their symptoms and improve their quality of life."

Dr David Gwynne, medical director at Boots Online Doctor, said prescribing decisions need to be made carefully on an individual patient basis, as "medical cannabis is not appropriate for everyone". Gwynne said: "SureLeaf has therefore been designed with strong clinical safeguards and specialist oversight at every stage, so treatment is only considered for patients where it is clinically appropriate. Our priority is to ensure patients receive responsible, clinically led care, from their initial specialist assessment through to ongoing monitoring and review once treatment begins."